I way I look at this company is that its currently valued significantlybelow its replacement cost (very low Q-ratio) and therefore future downside islimited from this point (bear case). My base case is for a steady continuationof improvements in current businesses with share prices returning to cap raiselevels and bull case sees a huge spike once bio-dynamic organic infant formulais announced. Launching into a new niche segment of the IF market with LBsteering the ship will see the hype of 2017 return.
Intrinsic Value, page-15
Add MBH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.002(2.47%) |
Mkt cap ! $29.25M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.4¢ | 8.3¢ | $15.78K | 189.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31518 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.42pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 8.3¢ | 8.3¢ | 8.3¢ | 54406 | ||
| Last updated 10.50am 31/05/2024 ? | |||||
| MBH (ASX) Chart |